Abstract:Membrane permeability plays an important role in oral drug absorption. Caco-2 and Madin-Darby Canine Kidney (MDCK) cell culture systems have been widely used for assessing intestinal permeability. Since most drugs are absorbed passively, Parallel Artificial Membrane Permeability Assay (PAMPA) has gained popularity as a low-cost and high-throughput method in early drug discovery when compared to high-cost, labor intensive cell-based assays. At the National Center for Advancing Translational Sciences (NCATS), PAMPA pH 5 is employed as one of the Tier I absorption, distribution, metabolism, and elimination (ADME) assays. In this study, we have developed a quantitative structure activity relationship (QSAR) model using our ∼6500 compound PAMPA pH 5 permeability dataset. Along with ensemble decision tree-based methods such as Random Forest and eXtreme Gradient Boosting, we employed deep neural network and a graph convolutional neural network to model PAMPA pH 5 permeability. The classification models trained on a balanced training set provided accuracies ranging from 71% to 78% on the external set. Of the four classifiers, the graph convolutional neural network that directly operates on molecular graphs offered the best classification performance. Additionally, an ∼85% correlation was obtained between PAMPA pH 5 permeability and in vivo oral bioavailability in mice and rats. These results suggest that data from this assay (experimental or predicted) can be used to rank-order compounds for preclinical in vivo testing with a high degree of confidence, reducing cost and attrition as well as accelerating the drug discovery process. Additionally, experimental data for 486 compounds (PubChem AID: 1645871) and the best models have been made publicly available (https://opendata.ncats.nih.gov/adme/).

Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors

Hepatitis C virus NS3 protease inhibitors: large, flexible molecules of peptide origin show satisfactory permeability across Caco-2 cells

Comparison of in vitro membrane permeabilities of diverse environmental chemicals with in silico predictions

Advances in Parallel Artificial Membrane Permeability Assay and Its Applications

Optimization of a Parallel Artificial Membrane Permeability Assay for the Fast and Simultaneous Prediction of Human Intestinal Absorption and Plasma Protein Binding of Drug Candidates: Application to Dibenz[b,f]azepine-5-Carboxamide Derivatives

PPO/PEO Modified Hollow Fiber Membranes Improved Sensitivity of 3D Cultured Hepatocytes to Drug Toxicity Via Suppressing Drug Adsorption on Membranes.

Antiviral Drug-Membrane Permeability: the Viral Envelope and Cellular Organelles

Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailability

Characterization and Applications of Permeabilized Hepatocytes in Drug Discovery

A comparison study of hepatic-compatibility among several semi-permeable membranes

Towards Prediction of in Vivo Exposure from a Permeability Perspective Using a 96-Well Caco-2 Assay

The impact of assay recovery on the apparent permeability, a function of lysosomal trapping

Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure-Activity Relationships

Cytotoxicity of PPARα/γ Dual Agonists C333H and P633H on HepG2 Cells Using High Content Analysis

Development of A Cell-Based Assay for Monitoring Hepatitis C Virus Ns3/4a Protease Activity

A new PAMPA model proposed on the basis of a synthetic phospholipid membrane.

Identification of a Novel Class of Cyclic Penta-Peptides against Hepatitis C Virus as p7 Channel Blockers

Permeation Prediction of M100240 Using the Parallel Artificial Membrane Permeability Assay.

Evaluation of interactions between the hepatitis C virus NS3/4A and sulfonamidobenzamide based molecules using molecular docking, molecular dynamics simulations and binding free energy calculations

Study on cell permeability coefficients of a new Pim-1 kinase inhibitor KY-C002 by using Caco-2 cell monolayer

Estimation of Inhibitory Quotient Using a Comparative Equilibrium Dialysis Assay for Prediction of Viral Response to Hepatitis C Virus Inhibitors